The effects of human macrophage inflammatory protein-1α and its genetically modified variant, BB10010, on phagocyte function

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 1, 1997, Pages 41-50

  Williams, Sion L ^a   Addison, Ian E ^a   Mollapour, Elahe ^a   Czaplewski, Lloyd G ^b   Linch, David C ^a   Roberts, Pamela J ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Calcium mobilization; Cell adhesion molecules; Chemokines; Chemotaxis; NADPH oxidase

Indexed keywords

ALANINE; CALCIUM ION; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RECEPTOR; SUPEROXIDE; VERY LATE ACTIVATION ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; CALCIUM MOBILIZATION; CELL FUNCTION; CELL MIGRATION; CELL PROTECTION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; STEM CELL;

CALCIUM; CELL ADHESION MOLECULES; CELL LINE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INTRACELLULAR FLUID; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTES; NADPH OXIDASE; NEUTROPHILS; PHAGOCYTES; RESPIRATORY BURST; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 0030752683     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Taub DD, Oppenheim JJ, Chemokines, inflammation and the immune system. Therapeutic Immunol (1994) 1: 229-41.
2. Schall TJ, Bacon KB, Chemokines, leukocyte trafficking and inflammation. Curr Op in Immunol (1994) 6: 865-73.
3. Murphy PM, The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol (1994) 12: 593-633.
4. Power CA, Wells TNC, Cloning and characterization of human chemokine receptors. Trends Pharmacol Sci (1996) 17: 209-13.
5. Lord BI, Mori KJ, Wright EG, Lajtha LG, An inhibitor of stem cell proliferation in normal bone marrow. Br J Haematol (1976) 34: 441-7.
6. Graham GJ, Wright EG, Hewick R et al, Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 344: 442-4.
7. Broxmeyer HE, Sherry B, Lu L et al, Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood (1990) 76: 1110-16.
8. Avalos BR, Bartynski KJ, Elder PJ et al, The active monomeric form of macrophage inflammatory protein-1α interacts with high- and low-affinity classes of receptors on human haematopoietic cells. Blood (1994) 84: 1790-801.
9. Hunter MG, Bawden L, Brotherton D et al, BB-10010: an active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties. Blood (1995) 86: 440-8.
10. Dunlop DJ, Wright EG, Lorimore S et al, Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo. Blood (1992) 79: 2221-5.
11. Lord BI, Dexter TM, Clements JM et al, Macrophage inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood (1992) 79: 2605-9.
12. McCourt M, Brotherton D, Comer M et al, BB-10010, a variant of the human stem cell inhibitor LD78, produces a rapid increase in both mature white blood cells and circulating haemopoietic progenitors. Bone Marrow Transplant (1994) 14 (Suppl 2): S34.
13. Lord BI, Woolford LB, Wood LM et al, Mobilization of early hematopoietic cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1α Blood (1995) 85: 3412-15.
14. Wang, JM, Sherry B, Fivash MJ et al, Human recombinant macrophage inflammatory protein-1α and -β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol (1993) 150: 3022-9.
15. Schall TJ, Bacon K, Camp RD et al, Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med (1993) 177: 1821-6.
16. Taub DD, Conlon K, Lloyd AR et al, Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science (1994) 260: 355-8.
17. Cook DN, Beck MA, Coffman TM et al, Requirement of MIP-1α for an inflammatory response to viral infection. Science (1995) 269: 83-5.
18. - T cells. Science (1996) 270: 1811-14.
19. Alkhatib G, Combadiere C, Broder CC et al, CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 272: 1955-8.
20. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 381: 667-73.
21. Deng H-K, Rong L, Ellmeier W et al, Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 381: 661-6.
22. McColl SR, Hachicha M, Levasseur S et al, Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory proteins-1α and -1β. J Immunol (1993) 150: 4550-60.
23. Wolpe SD, Davatelis G, Sherry B et al, Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med (1988) 167: 570-81.
24. Patel SR, Evans S, Dunne K et al, Characterization of the quarternary structure and conformational properties of the human stem cell inhibitor protein LD78 in solution. Biochemistry (1993) 32: 5466-71.
25. Mantel C, Kim YJ, Cooper S, Broxmeyer B, Polymerization of murine macrophage inflammatory protein-1α inactivates its myelosuppressive effects in vitro: the active form is a monomer. Proc Natl Acad Sci USA (1993) 90: 2232-6.
26. Roberts PJ, Pizzey AR, Khwaja A et al, The effects of interleukin-8 on neutrophil fMetLeuPhe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br J Haematol (1993) 84: 586-94.
27. Macintyre EA, Tatham PER, Abdul-Gaffar R, Linch DC, The effects of pertussis toxin on human lymphocytes. Immunology (1988) 64: 427-32.
28. Addison IE, Babbage JW, A raft technique for chemotaxis: a versatile method suitable for clinical studies. J Immunol Meth (1976) 10: 385-8.
29. Babior BM, Kipnes RS, Curnutte JT, Biological defence mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest (1973) 52: 741-4.
30. Jaswon MS, Khwaja A, Roberts PJ et al, The effects of rhGM-CSF on the neutrophil respiratory burst when studied in whole blood. Br J Haematol (1990) 75: 181-7.
31. Yuo A, Kitagawa S, Kashara T et al, Stimulation and priming of human neutrophils by interleukin-8; cooperation with tumor necrosis factor and colony-stimulating factors. Blood (1991) 78: 2708-14.
32. Combadiere C, Ahuja SK, Murphy PM, Cloning, chromosomal localization, and RNA expression of a human β chemokine receptor-like gene. DNA and Cell Biol (1995) 14: 673-80.
33. Chuluyan HE, Schall TJ, Yoshimura T, Issekutz AC, IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1α, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1. J Leuk Biol (1995) 58: 71-9.
34. Petersen F, Ludwig A, Flad H-D, Brandt E, TNF-α renders human neutrophils responsive to platelet factor 4. J Immunol (1996) 156: 1954-62.
35. Miyazaki M, Kodama H, Fujita I et al, Dimeric chemotactic peptides discriminate between chemotaxis and superoxide production of human neutrophils. J Biochem (1995) 117: 489-94.